HHT | Rare Diseases Clinical Research Network

Patient Spotlight: Anthony Anzell Fights Hereditary Hemorrhagic Telangiectasia with Endurance and Education Dakota Campbell Tue, 10/19/2021 - 14:05

Anthony Anzell, PhD

Anthony Anzell, PhD, is a postdoctoral fellow at the University of Pittsburgh studying hereditary hemorrhagic telangiectasia (HHT). He also happens to be an HHT patient. Here, Dr. Anzell shares his HHT journey, from diagnosis, to ultramarathons, to the lab.

BVMC

Brain Vascular Malformation Consortium

Patient Spotlight

hereditary hemorrhagic telangiectasia

HHT

Spotlight on RDCRN Consortia: Vasculitis Clinical Research Consortium Anonymous (not verified) Fri, 01/06/2012 - 10:53

The Vasculitis Clinical Research Consortium (VCRC) is an international, multi-center, clinical research infrastructure for the study of vasculitis.

Subscribe to HHT

The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). The RDCRN websites are hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818.